
Alector, Inc. (ALEC)
Last updated: 2026-10-21 21:30:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Alector, Inc. (ALEC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.87, with a market capitalization of $217.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.09 to $3.27. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$217.73M | |
$1.97 | |
$43.32 | |
$0.87 | |
$1.97 | |
881.46K | |
3.17M | |
-- | |
$3.27 | |
$1.09 | |
-- | |
-- |
Alector, Inc. (ALEC) After-Hours Stock Price
Alector, Inc. (ALEC) is trading at $1.88 in after-hours trading as of 2026-10-21 21:27:00, down 4.52% ($0.09) from the regular-session close of $1.97.
After-hours trading shows how investors are pricing ALEC after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Alector, Inc. (ALEC) 7-Day Stock Price Change
Over the past seven days, Alector, Inc. (ALEC) moved from $2.08 to $1.87, representing a decline of 10.34% ($0.22).
The stock traded between $1.77 and $2.18 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.65 million shares, down versus the previous seven-day period, indicating lower trading activity.
ALEC 52-Week Price Position
Position in Range: 35.6%
ALEC is currently trading at $1.87, placing it 35.6% of the way from its 52-week low of $1.09 to its 52-week high of $3.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Alector, Inc. (ALEC)?
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Alector, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 103 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Alector, Inc. (ALEC) Stock on MEXC
Eligible investors can buy real shares of Alector, Inc. (ALEC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Alector, Inc. (ALEC) stock price today?
2.Is ALEC stock going up or down today?
3.What is ALEC pre-market price?
4.What is ALEC after-hours price?
5.Is ALEC stock trading now?
6.Where does ALEC sit relative to its 52-week high and low?
7.What sector is Alector, Inc. in?
8.What is Alector, Inc.'s market capitalization and where is it listed?
9.How is ALEC valued in terms of P/E ratio and EPS?
10.Does Alector, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ALEC Stock Calculator
Estimate the value between ALEC shares and USD.
ALEC Shares to USD
1.00 ALEC shares = 1.865 USD
Calculations are estimates based on the latest available price and are for reference only.


